红光治疗近视——中国当前的监管变化

IF 7.8 1区医学 Q1 OPHTHALMOLOGY

JAMA ophthalmology Pub Date : 2025-01-23 DOI:10.1001/jamaophthalmol.2024.5977

Ya Xing Wang, Ningli Wang, Tien Yin Wong

引用次数: 0

摘要

本文讨论了在中国用于儿童和青少年近视治疗的眼科设备——红光疗法，包括其发展和使用、安全问题以及对该设备最近监管变化和重新分类的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Red Light Therapy for Myopia—Current Regulatory Changes in China

This Viewpoint discusses the ophthalmic device, red light therapy, for myopia treatment in children and adolescents in China, including its development and use, safety concerns, and implications surrounding recent regulatory changes and reclassification of this device.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JAMA ophthalmology OPHTHALMOLOGY-

CiteScore

13.20

自引率

3.70%

发文量

340

期刊介绍： JAMA Ophthalmology, with a rich history of continuous publication since 1869, stands as a distinguished international, peer-reviewed journal dedicated to ophthalmology and visual science. In 2019, the journal proudly commemorated 150 years of uninterrupted service to the field. As a member of the esteemed JAMA Network, a consortium renowned for its peer-reviewed general medical and specialty publications, JAMA Ophthalmology upholds the highest standards of excellence in disseminating cutting-edge research and insights. Join us in celebrating our legacy and advancing the frontiers of ophthalmology and visual science.